ATOSSA THERAPEUTICS, INC.: 10-Q filed 2018-11-14
What ATOSSA THERAPEUTICS, INC. reported in its quarterly report filed 2018-11-14 (fiscal Q3 2018): 25 published measures, 67 facts as tagged in accession 0001437749-18-020638.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-11-14
- Fiscal period
- fiscal Q3 2018
- Accession
- 0001437749-18-020638 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ATOSSA THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 14,124,372 | USD | |
| At 2017-12-31 | 8,164,094 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 10,569,109 | USD | |
| At 2017-12-31 | 6,938,687 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 12,935,587 | USD | |
| At 2017-12-31 | 7,217,469 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -3,309,866 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -9,326,825 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -2,184,510 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -6,129,553 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | -6,517,985 | USD | 273 |
| 2017-01-01 to 2017-09-30 | -4,911,268 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 12,290,551 | USD | 273 |
| 2017-01-01 to 2017-09-30 | 4,616,969 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | -54,448 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | -74,753,154 | USD | |
| At 2017-12-31 | -65,426,329 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 57,804 | USD | |
| At 2017-12-31 | 11,467 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -3,309,970 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -9,327,067 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -2,055,927 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -5,655,781 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 13,922,943 | USD | |
| At 2017-12-31 | 7,898,034 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 3,555,263 | USD | |
| At 2017-12-31 | 1,225,407 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 550,704 | USD | |
| At 2017-12-31 | 334,901 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 55,107 | USD | |
| At 2017-12-31 | 75,686 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 3,309,970 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 9,327,067 | USD | 273 |
| 2017-07-01 to 2017-09-30 | 2,055,927 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 5,655,781 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 1,421,851 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 3,360,563 | USD | 273 |
| 2017-07-01 to 2017-09-30 | 742,450 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 2,110,846 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 5,523,255 | shares | |
| At 2017-12-31 | 2,651,952 | shares |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 88,518 | USD | |
| At 2017-12-31 | 178,907 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 51,673 | USD | |
| At 2017-12-31 | 90,105 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -3,309,866 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -9,326,825 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -2,184,510 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -6,129,553 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -3,309,866 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -20,806,133 | USD | 273 |
| 2018-04-01 to 2018-06-30 | -15,621,885 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -17,496,267 | USD | 181 |
| 2017-07-01 to 2017-09-30 | -2,184,510 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -8,697,685 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 1,888,119 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 5,966,504 | USD | 273 |
| 2017-07-01 to 2017-09-30 | 1,313,477 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 3,544,935 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 28,690 | USD | 273 |
| 2017-01-01 to 2017-09-30 | 102,074 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 104 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 242 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -283 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -208 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 215,803 | USD | 273 |
| 2017-01-01 to 2017-09-30 | 126,079 | USD | 273 |
Inspect the source
- Entity
- ATOSSA THERAPEUTICS, INC. / CIK 0001488039
- Captured
- 2026-09-20T09:09:43.864Z
- SEC response SHA-256
1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))